321 related articles for article (PubMed ID: 28959799)
1. Cytokine and Lipid Mediator Regulation of Group 2 Innate Lymphoid Cells (ILC2s) in Human Allergic Airway Disease.
Cavagnero K; Doherty TA
J Cytokine Biol; 2017 Aug; 2(2):. PubMed ID: 28959799
[TBL] [Abstract][Full Text] [Related]
2. Group 2 Innate Lymphoid Cells in Airway Diseases.
Kato A
Chest; 2019 Jul; 156(1):141-149. PubMed ID: 31082387
[TBL] [Abstract][Full Text] [Related]
3. Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease.
Karta MR; Broide DH; Doherty TA
Curr Allergy Asthma Rep; 2016 Jan; 16(1):8. PubMed ID: 26746844
[TBL] [Abstract][Full Text] [Related]
4. Lipid-mediated innate lymphoid cell recruitment and activation in aspirin-exacerbated respiratory disease.
Cavagnero KJ; Doherty TA
Ann Allergy Asthma Immunol; 2021 Feb; 126(2):135-142. PubMed ID: 32950684
[TBL] [Abstract][Full Text] [Related]
5. [The role of group 2 innate lymphoid cells (ILC2) in respiratory allergic diseases: An update].
Luo C; Liu S; Ren Q; Peng S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jun; 39(6):552-557. PubMed ID: 37340924
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
[TBL] [Abstract][Full Text] [Related]
7. Regulation of type 2 innate lymphoid cell-dependent airway hyperreactivity by butyrate.
Thio CL; Chi PY; Lai AC; Chang YJ
J Allergy Clin Immunol; 2018 Dec; 142(6):1867-1883.e12. PubMed ID: 29522844
[TBL] [Abstract][Full Text] [Related]
8. T cells are necessary for ILC2 activation in house dust mite-induced allergic airway inflammation in mice.
Li BW; de Bruijn MJ; Tindemans I; Lukkes M; KleinJan A; Hoogsteden HC; Hendriks RW
Eur J Immunol; 2016 Jun; 46(6):1392-403. PubMed ID: 27062360
[TBL] [Abstract][Full Text] [Related]
9. Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target.
Jin J; Sunusi S; Lu H
J Int Med Res; 2022 Jan; 50(1):3000605211053156. PubMed ID: 35048721
[TBL] [Abstract][Full Text] [Related]
10. Cysteinyl leukotriene E
Salimi M; Stöger L; Liu W; Go S; Pavord I; Klenerman P; Ogg G; Xue L
J Allergy Clin Immunol; 2017 Oct; 140(4):1090-1100.e11. PubMed ID: 28115217
[TBL] [Abstract][Full Text] [Related]
11. Innate Lymphoid Cells in Airway Inflammation.
Asghar Pasha M; Yang Q
Adv Exp Med Biol; 2021; 1303():183-191. PubMed ID: 33788194
[TBL] [Abstract][Full Text] [Related]
12. Group 2 innate lymphoid cells and asthma.
Kabata H; Moro K; Koyasu S; Asano K
Allergol Int; 2015 Jul; 64(3):227-34. PubMed ID: 26117253
[TBL] [Abstract][Full Text] [Related]
13. Type 2 innate lymphoid cells: at the cross-roads in allergic asthma.
van Rijt L; von Richthofen H; van Ree R
Semin Immunopathol; 2016 Jul; 38(4):483-96. PubMed ID: 26965110
[TBL] [Abstract][Full Text] [Related]
14. Group 2 innate lymphoid cells (ILC2s): The spotlight in asthma pathogenesis and lung tissue injury.
Sadik S; Lu Y; Zhu S; Cai J; Mi LL
Allergol Immunopathol (Madr); 2021; 49(2):208-216. PubMed ID: 33641310
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase Cθ controls type 2 innate lymphoid cell and T
Madouri F; Chenuet P; Beuraud C; Fauconnier L; Marchiol T; Rouxel N; Ledru A; Gallerand M; Lombardi V; Mascarell L; Marquant Q; Apetoh L; Erard F; Le Bert M; Trovero F; Quesniaux VFJ; Ryffel B; Togbe D
J Allergy Clin Immunol; 2017 May; 139(5):1650-1666. PubMed ID: 27746240
[TBL] [Abstract][Full Text] [Related]
16. The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma.
Matsuyama T; Matsuyama H; Dotake Y; Takagi K; Machida K; Inoue H
Front Immunol; 2022; 13():930862. PubMed ID: 35911708
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms to Suppress ILC2-induced Airway Inflammation.
Kabata H; Moro K; Koyasu S; Fukunaga K; Asano K; Betsuyaku T
Ann Am Thorac Soc; 2016 Mar; 13 Suppl 1():S95. PubMed ID: 27027961
[TBL] [Abstract][Full Text] [Related]
18. T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice.
Li BWS; de Bruijn MJW; Lukkes M; van Nimwegen M; Bergen IM; KleinJan A; GeurtsvanKessel CH; Andeweg A; Rimmelzwaan GF; Hendriks RW
Eur J Immunol; 2019 Jan; 49(1):144-156. PubMed ID: 29762870
[TBL] [Abstract][Full Text] [Related]
19. Lower serum 15-HETE level predicts nasal ILC2 accumulation during COX-1 inhibition in AERD.
Badrani JH; Cavagnero K; Eastman JJ; Kim AS; Strohm A; Yan C; Deconde A; Zuraw BL; White AA; Christiansen SC; Doherty TA
J Allergy Clin Immunol; 2023 Nov; 152(5):1330-1335.e1. PubMed ID: 37543185
[TBL] [Abstract][Full Text] [Related]
20. Airway innate lymphoid cells in the induction and regulation of allergy.
Doherty TA; Broide DH
Allergol Int; 2019 Jan; 68(1):9-16. PubMed ID: 30473412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
